The U.S. Food and Drug Administration has granted a full final approval to Gilead Sciences Inc.’s remdesivir, making it the first Covid-19 treatment deemed safe and effective by the regulator, the company said Thursday. Remdesivir has been widely used to treat hospitalized Covid-19 patients since May, when it received a provisional clearance from regulators known as an emergency-use authorization. Emergency authorizations are used to quickly get experimental drugs to patients without other treatment options in the event of...

Source: Wall Street Journal October 22, 2020 22:07 UTC